医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

医薬品・デバイス

血液がん：AOPヘルスが、米国血液学会（ASH）第65回年次総会で発表する真性多血症患者における新知見を発表

バイオテクノロジーヘルスケアヘルス一般腫瘍学製薬　 TimeLine: AOPヘルス ASH 米国血液学会血液がん

2023年12月08日

血癌：AOP Health宣布将在美国血液学学会(ASH)第65届年会上发表真性红细胞增多症患者的最新研究成果

バイオテクノロジーヘルスケアヘルス一般腫瘍学製薬　 TimeLine: AOP Health宣布将在美国血液学学会 ASH 发表真性红细胞增多症患者的最新研究成果血癌

2023年12月08日

ArteraAI and GenesisCare Partner to Launch the First Australian-Based Clinical Trial

ArteraAI and GenesisCare Partner to Launch the First Australian-Based Clinical Trial

ヘルスケア病院腫瘍学臨床試験　 TimeLine: ArteraAI and GenesisCare Partner to Launch the First Australian-Based Clinical Trial

2023年12月08日

Validation Data on a Novel Prognostic Test Developed by GRAIL in Stage I Lung Cancer Presented at North America Conference on Lung Cancer

Validation Data on a Novel Prognostic Test Developed by GRAIL in Stage I Lung Cancer Presented at North America Conference on Lung Cancer

バイオテクノロジーヘルスケアヘルス一般マネージド・ケア医療機器病院腫瘍学臨床試験製薬遺伝学　 TimeLine: Validation Data on a Novel Prognostic Test Developed by GRAIL in Stage I Lung Cancer Presented at North America Conference on Lung Cancer

2023年12月07日

Kubota Vision Announces Agreement with AUROLAB for Development, Manufacturing, Supply, and Distribution License of eyeMO

Kubota Vision Announces Agreement with AUROLAB for Development, Manufacturing, Supply, and Distribution License of eyeMO

バイオテクノロジーヘルスケアヘルス一般医療機器医療管理病院眼科医療　 TimeLine: Manufacturing Supply

2023年12月07日

Kubota Vision Announces Vendor Agreement with IQVIA for eyeMO

Kubota Vision Announces Vendor Agreement with IQVIA for eyeMO

ヘルスケア医療機器眼科医療臨床試験　 TimeLine: eyeMO IQVIA for Kubota Vision Announces Vendor Agreement with

2023年12月07日

Kaneka收购Japan Medical Device Technology

Kaneka收购Japan Medical Device Technology

ヘルスケア医療機器医療用品外科心臓学　 TimeLine: Kaneka收购Japan Medical Device Technology

2023年12月07日

Taiwan Bio and TRACT Therapeutics, Inc. Announce Strategic Partnership to Advance a Novel Therapeutic Approach for Preventing Rejection in Solid Organ Transplant

Taiwan Bio and TRACT Therapeutics, Inc. Announce Strategic Partnership to Advance a Novel Therapeutic Approach for Preventing Rejection in Solid Organ Transplant

バイオテクノロジーヘルスケア外科病院臨床試験製薬遺伝学　 TimeLine: Announce Strategic Partnership Inc Rejection in Solid Organ Transplant Taiwan Bio and TRACT Therapeutics to Advance a Novel Therapeutic Approach for Preventing

2023年12月06日

Coya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter into an Exclusive Collaboration for Development and Commercialization of COYA 302, an Investigational Combination Therapy for Treatment of Amyotrophic Lateral Sclerosis (ALS)

Coya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter into an Exclusive Collaboration for Development and Commercialization of COYA 302, an Investigational Combination Therapy for Treatment of Amyotrophic Lateral Sclerosis (ALS)

バイオテクノロジーヘルスケアヘルス一般幹細胞感染症臨床試験製薬　 TimeLine: 302 ALS an Investigational Combination Therapy for Treatment of Amyotrophic Lateral Sclerosis and Dr. Reddy’s Laboratories Enter into an Exclusive Collaboration for Development and Commercialization of COYA Coya Therapeutics Inc

2023年12月06日

PDC*line Pharma Completes Enrolment of Four Cohorts of Patients in PDC-LUNG-101 Phase I/II Clinical Trial

バイオテクノロジーヘルスケア腫瘍学臨床試験製薬　 TimeLine: II Clinical Trial PDC*line Pharma Completes Enrolment of Four Cohorts of Patients in PDC-LUNG-101 Phase

2023年12月06日